Featured Research

from universities, journals, and other organizations

Most Sexual Assaults Drug Facilitated, Study Claims

Date:
May 13, 2006
Source:
University Of Illinois At Chicago
Summary:
Almost 62 percent of sexual assaults were found to be drug facilitated, and almost 5 percent of the victims were given classic 'date-rape' drugs, according to a new study at the University of Illinois at Chicago.

Almost 62 percent of sexual assaults were found to be drug facilitated, and almost 5 percent of the victims were given classic 'date-rape' drugs, according to a new study at the University of Illinois at Chicago.

An estimated 100,000 sexual assaults are committed in the United States each year, and the FBI says that number could be three times higher if all cases were reported, said Adam Negrusz, associate professor of forensic sciences in the UIC College of Pharmacy.

Negrusz, lead author of the study titled "Estimate of the Incidence of Drug-Facilitated Sexual Assault in the U.S.," said individuals who use drugs, with or without alcohol, are thought to be at a significantly higher risk for sexual assault.

"In some cases the substances are taken voluntarily by the victims, impairing their ability to make decisions," Negrusz said. "In other cases the substances are given to the victims without their knowledge, which may decrease their ability to identify a dangerous situation or to resist the perpetrator."

In about 80 percent of the cases the victim knows the assailant, he said, "while only 20 percent of sexual assaults are opportunistic."

The study, funded by the National Institute of Justice, can be accessed via the National Criminal Justice Reference Service at www.ncjrs.gov

The study collected data from 144 subjects who sought help in clinics located in Texas, California, Minnesota and Washington state. The subjects were from all ethnic backgrounds and ranged in age from 18 to 56, with a mean age of 26.6.

Each clinic was provided with sexual assault kits and asked to enroll willing sexual assault complainants. Subjects provided two urine samples and a hair specimen and completed a questionnaire that asked them to describe the assault and any drugs they were using.

"The urine and hair specimens were analyzed for about 45 drugs that have either been detected in sexual assault victims or whose pharmacology could be exploited for drug-facilitated sexual assaults," Negrusz said.

Two types of drug-facilitated sexual assault were identified: presumed surreptitious drugging, or willful drug use by the subject.

According to Negrusz, 61.8 percent of the subjects were found to have at least one of the 45 analyzed drugs in their system; 4.9 percent tested positive for the classic date-rape drugs, and 4.2 percent of the subjects had been drugged without their knowledge.

Four of the unwittingly-drugged victims, Negrusz said, tested positive for Rohypnol, a tranquilizer 10 times more potent than Valium that has been banned in the United States.

When the subject's voluntary drug use was queried, 35.4 percent were likely to have been impaired at the time of the sexual assault.

"This study demonstrated the need for toxicological analysis in sexual assault cases," Negrusz said, noting the high percentage of subjects who tested positive for drugs. "It also demonstrated that sexual assault complainants severely underreport their illegal drug usage. This could be corrected if the administering nursing staff was better educated on taking a truthful drug history."

The study also confirmed that drug-facilitated sexual assault is more often due to the subject's own drug use, he said, rather than surreptitious drugging by the perpetrator.

Robert Gaensslen, professor and head of the UIC forensic science program, and Matthew Juhascik, who received his doctoral degree in biopharmaceutical sciences from UIC, assisted with the study.


Story Source:

The above story is based on materials provided by University Of Illinois At Chicago. Note: Materials may be edited for content and length.


Cite This Page:

University Of Illinois At Chicago. "Most Sexual Assaults Drug Facilitated, Study Claims." ScienceDaily. ScienceDaily, 13 May 2006. <www.sciencedaily.com/releases/2006/05/060513122928.htm>.
University Of Illinois At Chicago. (2006, May 13). Most Sexual Assaults Drug Facilitated, Study Claims. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2006/05/060513122928.htm
University Of Illinois At Chicago. "Most Sexual Assaults Drug Facilitated, Study Claims." ScienceDaily. www.sciencedaily.com/releases/2006/05/060513122928.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins